New Zealand markets closed

Regenerative Medical Technology Group Inc. (MSSV)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.03500.0000 (0.00%)
At close: 11:25AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 437.29k
Enterprise value 18.66M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.18
Price/book (mrq)N/A
Enterprise value/revenue 7.64
Enterprise value/EBITDA -9.18

Trading information

Stock price history

Beta (5Y monthly) 1.35
52-week change 385.19%
S&P500 52-week change 324.60%
52-week high 30.0600
52-week low 30.0072
50-day moving average 30.0392
200-day moving average 30.0276

Share statistics

Avg vol (3-month) 39.9k
Avg vol (10-day) 37.17k
Shares outstanding 512.49M
Implied shares outstanding 612.49M
Float 811.95M
% held by insiders 18.66%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 326 Sept 2018
Ex-dividend date 4N/A
Last split factor 21:1000
Last split date 326 Sept 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-10.02%

Management effectiveness

Return on assets (ttm)-8.03%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)2.44M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)3.90%
Gross profit (ttm)N/A
EBITDA -386.06k
Net income avi to common (ttm)-10.1M
Diluted EPS (ttm)-0.8200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)579.35k
Total cash per share (mrq)0.05
Total debt (mrq)18.8M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.03
Book value per share (mrq)-1.90

Cash flow statement

Operating cash flow (ttm)-318.01k
Levered free cash flow (ttm)766.71k